Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Página oficial de la convocatoria ↗
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.
Historial de cambios
First seen 28 Sept 2026, last checked 04 Oct 2026. 5 recorded versions.
- 04 Oct 2026 · ec798e27ad64
- 02 Oct 2026 · 63111ab3b636
- 01 Oct 2026 · 5ea7d88bde02
- 30 Sept 2026 · 2c9b9a42d00d
- 29 Sept 2026 · 27a1d1542b57